BE554934A
(es)
|
1956-02-13 |
1900-01-01 |
|
|
BE787580A
(fr)
|
1971-08-13 |
1973-02-14 |
Hoechst Ag |
Procede de preparation de derives du furanne
|
BE787576A
(fr)
|
1971-08-13 |
1973-02-14 |
Hoechst Ag |
Derives de benzofuranne et leur utilisation comme azureurs optiques
|
GB1409865A
(en)
|
1973-02-13 |
1975-10-15 |
Science Union & Cie |
Dihydropyridines derivatives their preparation and pharmaceu tical compositions containing them
|
GB1593417A
(en)
|
1976-12-22 |
1981-07-15 |
Squibb & Sons Inc |
Carbocyclic-fused pyrazolopyridine derivatives
|
US4062858A
(en)
|
1976-12-22 |
1977-12-13 |
E. R. Squibb & Sons, Inc. |
Derivatives of 5,6-dihydrobenzo[5,6]cyclohepta[1,2-b]pyrazolo[4,3-e]pyridin-11(1H)-ones and 11(1H)-imines
|
DE2964427D1
(en)
|
1978-10-04 |
1983-02-03 |
Ciba Geigy Ag |
Process for the preparation of furanyl-benzazoles
|
DE2853765A1
(de)
|
1978-12-13 |
1980-06-26 |
Bayer Ag |
Verfahren zur herstellung von benzimidazolylbenzofuranen
|
DE2904829A1
(de)
|
1979-02-08 |
1980-08-14 |
Bayer Ag |
Verfahren zur herstellung von benzimidazolylbenzofuran
|
MW2380A1
(en)
|
1979-06-29 |
1982-03-10 |
Wellcome Found |
Pharmaceutical ethers,preparation,use and intermediates therefor and their preparation
|
GR76950B
(es)
|
1980-12-18 |
1984-09-04 |
Wellcome Found |
|
JPS5929667A
(ja)
|
1982-08-13 |
1984-02-16 |
Otsuka Pharmaceut Co Ltd |
カルボスチリル誘導体および強心剤
|
US4478834A
(en)
|
1983-02-11 |
1984-10-23 |
Usv Pharmaceutical Corporation |
Dihydropyridines and their use in the treatment of asthma
|
GB8402740D0
(en)
|
1984-02-02 |
1984-03-07 |
Scras |
Furo-(3 4-c)-pyridine derivatives
|
JPS6140236A
(ja)
|
1984-08-02 |
1986-02-26 |
Yamanouchi Pharmaceut Co Ltd |
ハイドロキノン誘導体
|
DE3431004A1
(de)
|
1984-08-23 |
1986-03-06 |
Hoechst Ag, 6230 Frankfurt |
Neue 3-pyridylverbindungen und verfahren zu ihrer herstellung
|
DD226590A1
(de)
|
1984-09-07 |
1985-08-28 |
Univ Leipzig |
Mittel zur phagenhemmung in mikrobiellen produktionsprozessen
|
GB8603475D0
(en)
|
1986-02-12 |
1986-03-19 |
Glaxo Group Ltd |
Chemical compounds
|
DK111387A
(da)
|
1986-03-05 |
1987-09-06 |
Otsuka Pharma Co Ltd |
Carbostyrilderivater og salte deraf, laegemiddel indeholdende saadanne derivater samt fremgangsmaade til fremstilling af derivaterne
|
US4831041A
(en)
|
1986-11-26 |
1989-05-16 |
Fujisawa Pharmaceutical Co., Ltd. |
Imidazopyridine compounds and processes for preparation thereof
|
EP0278686A1
(en)
|
1987-02-07 |
1988-08-17 |
The Wellcome Foundation Limited |
Pyridopyrimidines methods for their preparation and pharmaceutical formulations thereof
|
DD258226A1
(de)
|
1987-03-05 |
1988-07-13 |
Fahlberg List Veb |
Verfahren zur herstellung von aroxymethylchinoxalinen
|
JPH07121937B2
(ja)
|
1987-03-18 |
1995-12-25 |
大塚製薬株式会社 |
カルボスチリル誘導体
|
JPS63258463A
(ja)
|
1987-04-14 |
1988-10-25 |
Kumiai Chem Ind Co Ltd |
2−フエノキシピリミジン誘導体及び除草剤
|
GB8711802D0
(en)
|
1987-05-19 |
1987-06-24 |
Fujisawa Pharmaceutical Co |
Dithioacetal compounds
|
GB8718940D0
(en)
|
1987-08-11 |
1987-09-16 |
Glaxo Group Ltd |
Chemical compounds
|
US4920131A
(en)
|
1987-11-03 |
1990-04-24 |
Rorer Pharmaceutical Corp. |
Quinoline derivatives and use thereof as antagonists of leukotriene D4
|
JP2650038B2
(ja)
|
1988-01-27 |
1997-09-03 |
サントリー株式会社 |
ピロリチジン化合物およびその用途
|
JPH01305081A
(ja)
|
1988-04-04 |
1989-12-08 |
E R Squibb & Sons Inc |
3―アシルアミノ―1―[[[(置換スルホニル)アミノ〕カルボニル〕アミノ〕―2―アゼチジノン類
|
US4952574A
(en)
|
1988-09-26 |
1990-08-28 |
Riker Laboratories, Inc. |
Antiarrhythmic substituted N-(2-piperidylmethyl)benzamides
|
IE81170B1
(en)
|
1988-10-21 |
2000-05-31 |
Zeneca Ltd |
Pyridine derivatives
|
DD276480A1
(de)
|
1988-10-26 |
1990-02-28 |
Fahlberg List Veb |
Verfahren zur herstellung von naphtho/2,1-b/fur-2-ylchinoxalinen
|
DD276479A1
(de)
|
1988-10-26 |
1990-02-28 |
Fahlberg List Veb |
Verfahren zur herstellung von benzo/b/fur-2-ylchinoxalinen
|
US5236917A
(en)
|
1989-05-04 |
1993-08-17 |
Sterling Winthrop Inc. |
Saccharin derivatives useful as proteolytic enzyme inhibitors and compositions and method of use thereof
|
IT1230859B
(it)
|
1989-06-05 |
1991-11-08 |
Corvi Camillo Spa |
2 alchinilfenoli sostituiti ad azione anti infiammatoria, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
|
GB2244054B
(en)
|
1990-04-19 |
1994-04-06 |
Ici Plc |
Pyridine derivatives
|
IE912064A1
(en)
|
1990-06-18 |
1991-12-18 |
Merck & Co Inc |
Inhibitors of hiv reverse transcriptase
|
KR100196559B1
(ko)
|
1990-06-19 |
1999-06-15 |
기따사또 이찌로 |
안지오텐신ii 길항작용을 함유하는 피리딘 유도체
|
NL9001752A
(nl)
|
1990-08-02 |
1992-03-02 |
Cedona Pharm Bv |
Nieuwe 1,4-dihydropyridinederivaten.
|
IL99731A0
(en)
|
1990-10-18 |
1992-08-18 |
Merck & Co Inc |
Hydroxylated pyridine derivatives,their preparation and pharmaceutical compositions containing them
|
JPH05301872A
(ja)
|
1992-04-23 |
1993-11-16 |
Kumiai Chem Ind Co Ltd |
ピコリン酸誘導体及び除草剤
|
US5403816A
(en)
|
1990-10-25 |
1995-04-04 |
Kumiai Chemical Industry Co., Ltd. |
Picolinic acid derivative and herbicidal composition
|
WO1992013841A1
(de)
|
1991-02-08 |
1992-08-20 |
Byk Gulden Lomberg Chemische Fabrik Gmbh |
Komplexbildner
|
JPH0641118A
(ja)
|
1991-05-31 |
1994-02-15 |
Kumiai Chem Ind Co Ltd |
ピコリン酸誘導体及び除草剤
|
US5185251A
(en)
|
1991-06-07 |
1993-02-09 |
Merck & Co., Inc. |
Microbial transformation of a substituted pyridinone using actinoplanacete sp. MA 6559
|
JP2600644B2
(ja)
|
1991-08-16 |
1997-04-16 |
藤沢薬品工業株式会社 |
チアゾリルベンゾフラン誘導体
|
FR2680512B1
(fr)
|
1991-08-20 |
1995-01-20 |
Adir |
Nouveaux derives de 2,4-thiazolidinedione, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
|
US5202243A
(en)
|
1991-10-04 |
1993-04-13 |
Merck & Co., Inc. |
Method of hydroxylating 3-[2-(benzoxazol-2-yl)ethyl]-5-ethyl-6-methyl-2-(1H)-pyridinone by incubation with liver slices
|
GB9203798D0
(en)
|
1992-02-21 |
1992-04-08 |
Fujisawa Pharmaceutical Co |
Quinolylbenzofuran derivatives,processes for preparation thereof and pharmaceutical composition comprising the same
|
EP0648209A1
(de)
|
1992-07-01 |
1995-04-19 |
Byk Gulden Lomberg Chemische Fabrik GmbH |
Kontrastmittel für die mr diagnostik
|
US5290941A
(en)
|
1992-10-14 |
1994-03-01 |
Merck & Co., Inc. |
Facile condensation of methylbenzoxazoles with aromatic aldehydes
|
US5521202A
(en)
|
1993-04-07 |
1996-05-28 |
Taiho Pharmaceutical Co., Ltd. |
Thiazolidine derivatives and pharmaceutical compositions containing the same
|
DE4318550A1
(de)
|
1993-06-04 |
1994-12-08 |
Boehringer Mannheim Gmbh |
Aryliden-4-oxo-2-thioxo-3- thiazolidincarbonsäuren, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
|
IL110151A
(en)
|
1993-06-30 |
1998-10-30 |
Sankyo Co |
Amid and urea histories and pharmaceutical preparations containing them
|
JPH0725882A
(ja)
|
1993-07-07 |
1995-01-27 |
Res Dev Corp Of Japan |
アクロメリン酸bおよびeを製造するための中間体と、その製造方法
|
ES2132284T3
(es)
|
1993-08-05 |
1999-08-16 |
Hoechst Marion Roussel Inc |
Derivados de carbamato de 2-(piperidin-4-il, piridin-4-il y tetrahidropiridin-4-il)-benzofurano-7, su preparacion y su uso como inhibidores de acetilcolinesterasa.
|
EP0640609A1
(en)
|
1993-08-24 |
1995-03-01 |
Ono Pharmaceutical Co., Ltd. |
Fused phenol derivatives having inhibitory activity on TXA2 synthetase, and 5-lipoxygenase and scavenging activity on oxygen species
|
US5880131A
(en)
|
1993-10-20 |
1999-03-09 |
Enzon, Inc. |
High molecular weight polymer-based prodrugs
|
US5840900A
(en)
|
1993-10-20 |
1998-11-24 |
Enzon, Inc. |
High molecular weight polymer-based prodrugs
|
US5965566A
(en)
|
1993-10-20 |
1999-10-12 |
Enzon, Inc. |
High molecular weight polymer-based prodrugs
|
US5605976A
(en)
|
1995-05-15 |
1997-02-25 |
Enzon, Inc. |
Method of preparing polyalkylene oxide carboxylic acids
|
WO1995014015A1
(en)
|
1993-11-19 |
1995-05-26 |
Ciba-Geigy Ag |
Benzothiophene derivatives possessing a methoxyimino substituent as microbicides
|
EP0658559A1
(de)
|
1993-12-14 |
1995-06-21 |
Chemisch Pharmazeutische Forschungsgesellschaft m.b.H. |
Thienothiazinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als 5-dipoxygenase und Cyclooxygenaseinhibitoren
|
DK0750631T3
(da)
|
1994-02-14 |
2000-10-23 |
Merrell Pharma Inc |
Mercaptoacetylamido-1,3,4,5-tetrahydrobenzo[c]azepin-3-ondisulfidderivater som enkephalinase- og ACE-inhibitorer
|
GB9420557D0
(en)
|
1994-10-12 |
1994-11-30 |
Zeneca Ltd |
Aromatic compounds
|
DE4442050A1
(de)
|
1994-11-25 |
1996-05-30 |
Hoechst Ag |
Heterospiroverbindungen und ihre Verwendung als Elektrolumineszenzmaterialien
|
US5650408A
(en)
|
1995-06-07 |
1997-07-22 |
Karanewsky; Donald S. |
Thiazolo benzazepine containing dual action inhibitors
|
TW434240B
(en)
|
1995-06-20 |
2001-05-16 |
Zeneca Ltd |
Aromatic compounds, preparation thereof and pharmaceutical composition comprising same
|
JP3895404B2
(ja)
|
1996-05-17 |
2007-03-22 |
興和株式会社 |
カルコン誘導体及びこれを含有する医薬
|
EP0923580A1
(en)
|
1996-07-26 |
1999-06-23 |
Dr. Reddy's Research Foundation |
Thiazolidinedione compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions thereof
|
WO1998008818A1
(en)
|
1996-08-26 |
1998-03-05 |
Genetics Institute, Inc. |
Inhibitors of phospholipase enzymes
|
US6630496B1
(en)
|
1996-08-26 |
2003-10-07 |
Genetics Institute Llc |
Inhibitors of phospholipase enzymes
|
AU4136197A
(en)
|
1996-09-09 |
1998-03-26 |
Kyowa Hakko Kogyo Co. Ltd. |
Pyrrolocarbazole derivatives
|
AU725228B2
(en)
|
1996-11-12 |
2000-10-12 |
Novartis Ag |
Novel herbicides
|
US6043389A
(en)
|
1997-03-11 |
2000-03-28 |
Mor Research Applications, Ltd. |
Hydroxy and ether-containing oxyalkylene esters and uses thereof
|
US5760232A
(en)
|
1997-06-16 |
1998-06-02 |
Schering Corporation |
Synthesis of intermediates useful in preparing bromo-substituted tricyclic compounds
|
US6214817B1
(en)
|
1997-06-20 |
2001-04-10 |
Monsanto Company |
Substituted pyridino pentaazamacrocyle complexes having superoxide dismutase activity
|
US6011042A
(en)
|
1997-10-10 |
2000-01-04 |
Enzon, Inc. |
Acyl polymeric derivatives of aromatic hydroxyl-containing compounds
|
US6111107A
(en)
|
1997-11-20 |
2000-08-29 |
Enzon, Inc. |
High yield method for stereoselective acylation of tertiary alcohols
|
EP1044201A4
(en)
|
1997-12-12 |
2001-10-31 |
Euro Celtique Sa |
3-SUBSTITUTED ADENINE FROM 2-THIOXANTHINES
|
CN1298404A
(zh)
|
1998-02-25 |
2001-06-06 |
遗传研究所有限公司 |
磷脂酶a2的抑制剂
|
WO1999047529A1
(en)
|
1998-03-18 |
1999-09-23 |
Ariad Pharmaceuticals, Inc. |
Heterocyclic signal transduction inhibitors, compositions containing them
|
US6214879B1
(en)
|
1998-03-24 |
2001-04-10 |
Virginia Commonwealth University |
Allosteric inhibitors of pyruvate kinase
|
US6153655A
(en)
|
1998-04-17 |
2000-11-28 |
Enzon, Inc. |
Terminally-branched polymeric linkers and polymeric conjugates containing the same
|
GB9810860D0
(en)
|
1998-05-20 |
1998-07-22 |
Hoechst Schering Agrevo Gmbh |
Substituted pyridine and pyrimidines, processes for their preparation and their use as pesticides
|
US6232320B1
(en)
|
1998-06-04 |
2001-05-15 |
Abbott Laboratories |
Cell adhesion-inhibiting antiinflammatory compounds
|
BR9910864A
(pt)
|
1998-06-04 |
2002-02-05 |
Abbott Lab |
Compostos anti-inflamatórios para inibição de aderência celular
|
GB9818627D0
(en)
|
1998-08-26 |
1998-10-21 |
Glaxo Group Ltd |
Improvements in dva vaccination
|
GB9823871D0
(en)
|
1998-10-30 |
1998-12-23 |
Pharmacia & Upjohn Spa |
2-Amino-thiazole derivatives, process for their preparation, and their use as antitumour agents
|
US20030060425A1
(en)
|
1998-11-24 |
2003-03-27 |
Ahlem Clarence N. |
Immune modulation method using steroid compounds
|
CZ20012112A3
(cs)
|
1998-12-14 |
2001-10-17 |
F. Hoffmann-La Roche Ag |
Derivát fenylglycinu
|
EP1150957A1
(en)
|
1998-12-31 |
2001-11-07 |
Aventis Pharmaceuticals Inc. |
N-carboxymethyl substituted benzolactams as inhibitors of matrix metalloproteinase
|
US6544980B2
(en)
|
1998-12-31 |
2003-04-08 |
Aventis Pharmaceuticals Inc. |
N-carboxymethyl substituted benzolactams as inhibitors of matrix metalloproteinase
|
MXPA01009733A
(es)
|
1999-03-31 |
2002-11-04 |
Basf Ag |
Diamidas del acido piridin-2,3-dicarboxilico.
|
US6251927B1
(en)
|
1999-04-20 |
2001-06-26 |
Medinox, Inc. |
Methods for treatment of sickle cell anemia
|
MXPA01011502A
(es)
|
1999-05-14 |
2003-08-20 |
Boehringer Ingelheim Pharma |
Compuestos de tipo profarmaco anti-tumorigenos, activados por enzimas.
|
US6184228B1
(en)
|
1999-05-25 |
2001-02-06 |
Anadys Pharmaceuticals, Inc. |
Anti-sickling agents: selection methods and effective compounds
|
WO2000075145A1
(en)
|
1999-06-03 |
2000-12-14 |
Abbott Laboratories |
Cell adhesion-inhibiting antiinflammatory compounds
|
AUPQ105499A0
(en)
|
1999-06-18 |
1999-07-08 |
Biota Scientific Management Pty Ltd |
Antiviral agents
|
HUP0201869A3
(en)
|
1999-06-28 |
2003-12-29 |
Janssen Pharmaceutica Nv |
Respiratory syncytial virus replication inhibitors
|
HUP0203514A3
(en)
|
1999-09-28 |
2004-01-28 |
Eisai Co Ltd |
Quinuclidine compounds and drugs containing them and process for preparation the same
|
CN1384814B
(zh)
|
1999-11-05 |
2015-11-25 |
艾米斯菲尔技术有限公司 |
用于送递活性剂的苯氧基羧酸化合物和组合物
|
AUPQ407699A0
(en)
|
1999-11-16 |
1999-12-09 |
Fujisawa Pharmaceutical Co., Ltd. |
Aminoalcohol derivatives
|
SI1103545T1
(en)
|
1999-11-29 |
2004-02-29 |
F. Hoffmann-La Roche Ag |
2-(3,5-Bis-trifluoromethyl-phenyl)-N-methyl-N-(6-morpholin-4-yl-4-o-tolyl-pyridin-3-yl)-isobutyramide
|
CA2396079A1
(en)
*
|
2000-01-07 |
2001-07-19 |
Transform Pharmaceuticals, Inc. |
High-throughput formation, identification, and analysis of diverse solid-forms
|
AU2001230537A1
(en)
|
2000-02-01 |
2001-08-14 |
Daiichi Pharmaceutical Co., Ltd. |
Pyridoxazine derivatives
|
US6506755B2
(en)
|
2000-02-03 |
2003-01-14 |
Hoffmann-La Roche Inc. |
Thiazolidinecarboxyl acids
|
AUPQ585000A0
(en)
|
2000-02-28 |
2000-03-16 |
Fujisawa Pharmaceutical Co., Ltd. |
Aminoalcohol derivatives
|
WO2001070663A2
(en)
|
2000-03-17 |
2001-09-27 |
Corixa Corporation |
Novel amphipathic aldehydes and their use as adjuvants and immunoeffectors
|
AUPQ841300A0
(en)
|
2000-06-27 |
2000-07-20 |
Fujisawa Pharmaceutical Co., Ltd. |
New aminoalcohol derivatives
|
IL153834A0
(en)
|
2000-07-14 |
2003-07-31 |
Hoffmann La Roche |
N-oxides as nk1 receptor antagonist prodrugs of 4-phenyl-pyridine derivatives
|
WO2002009723A2
(en)
|
2000-08-01 |
2002-02-07 |
Gmp Companies, Inc. |
Ammonium salts of hemoglobin allosteric effectors, and uses thereof
|
US6653313B2
(en)
|
2000-08-10 |
2003-11-25 |
Warner-Lambert Company Llc |
1,4-dihydropyridine compounds as bradykinin antagonists
|
JP4272338B2
(ja)
|
2000-09-22 |
2009-06-03 |
バイエル アクチェンゲゼルシャフト |
ピリジン誘導体
|
AUPR034000A0
(en)
|
2000-09-25 |
2000-10-19 |
Fujisawa Pharmaceutical Co., Ltd. |
Aminoalcohol derivatives
|
PL361690A1
(en)
|
2000-11-20 |
2004-10-04 |
Biovitrum Ab |
Piperazinylpyrazine compounds as agonist or antagonist of serotonin 5ht-2 receptor
|
JPWO2002051849A1
(ja)
|
2000-12-26 |
2004-04-22 |
第一製薬株式会社 |
Cdk4活性阻害剤
|
DE60139025D1
(de)
|
2000-12-28 |
2009-07-30 |
Takeda Pharmaceutical |
Alkansäurederivate, verfahren zu deren herstellung und deren verwendung
|
GB0102595D0
(en)
|
2001-02-01 |
2001-03-21 |
Virk Kuldip |
Smart solar
|
US20030022923A1
(en)
|
2001-03-01 |
2003-01-30 |
Medinox, Inc. |
Methods for treatment of sickle cell anemia
|
US6627646B2
(en)
*
|
2001-07-17 |
2003-09-30 |
Sepracor Inc. |
Norastemizole polymorphs
|
WO2003009807A2
(en)
|
2001-07-23 |
2003-02-06 |
Galileo Laboratories, Inc. |
Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods
|
JP2003075970A
(ja)
|
2001-08-31 |
2003-03-12 |
Konica Corp |
ハロゲン化銀カラー写真感光材料、カラー写真感光材料、その画像形成方法及びデジタル画像情報作製方法
|
KR100467313B1
(ko)
|
2001-11-22 |
2005-01-24 |
한국전자통신연구원 |
적색 유기 전기발광 화합물 및 그 제조 방법과 전기발광소자
|
GB0128499D0
(en)
|
2001-11-28 |
2002-01-23 |
Merck Sharp & Dohme |
Therapeutic agents
|
US20030187026A1
(en)
|
2001-12-13 |
2003-10-02 |
Qun Li |
Kinase inhibitors
|
TW200303302A
(en)
|
2001-12-19 |
2003-09-01 |
Atherogenics Inc |
Chalcone derivatives and their use to treat diseases
|
US20030190333A1
(en)
|
2002-02-04 |
2003-10-09 |
Corixa Corporation |
Immunostimulant compositions comprising aminoalkyl glucosaminide phosphates and saponins
|
WO2003088980A1
(en)
|
2002-04-18 |
2003-10-30 |
Embury Stephen H |
Method and composition for preventing pain in sickle cell patients
|
US6608076B1
(en)
|
2002-05-16 |
2003-08-19 |
Enzon, Inc. |
Camptothecin derivatives and polymeric conjugates thereof
|
GB0212785D0
(en)
|
2002-05-31 |
2002-07-10 |
Glaxo Group Ltd |
Compounds
|
NZ538134A
(en)
|
2002-08-08 |
2006-03-31 |
Smithkline Beecham Corp |
Thiophene compounds
|
KR100942073B1
(ko)
|
2002-08-23 |
2010-02-12 |
기린 홀딩스 가부시키가이샤 |
TGF β 저해 활성을 갖는 화합물 및 그것을 포함하여 이루어지는 의약 조성물
|
US7368578B2
(en)
|
2002-09-10 |
2008-05-06 |
Takeda Pharmaceutical Company Limited |
Five-membered heterocyclic compounds
|
ES2407090T3
(es)
|
2002-12-04 |
2013-06-11 |
Virginia Commonwealth University |
Uso de derivados heterocíclicos de carbaldehído contra la anemia de células falciformes
|
AU2003303239A1
(en)
|
2002-12-19 |
2004-07-14 |
Atherogenics, Inc. |
Process of making chalcone derivatives
|
CA2509835A1
(en)
|
2002-12-25 |
2004-07-15 |
Kissei Pharmaceutical Co., Ltd. |
Nitrogen-containing heterocyclic derivatives, medicinal compositions containing the same and medicinal use thereof
|
EP1596818B1
(de)
|
2003-02-24 |
2006-05-03 |
Randolph Dr. Dr. Prof. Riemschneider |
Kosmetische zusammensetzung mit whitening-effekt, verfahren zu ihrer herstellung und ihre verwendung
|
US20040186077A1
(en)
|
2003-03-17 |
2004-09-23 |
Medicure International Inc. |
Novel heteroaryl phosphonates as cardioprotective agents
|
ZA200507752B
(en)
|
2003-03-28 |
2007-01-31 |
Threshold Pharmaceuticals Inc |
Compositions and methods for treating cancer
|
EP1613613B1
(en)
|
2003-04-11 |
2021-06-02 |
Genzyme Corporation |
Cxcr4 chemokine receptor binding compounds
|
EP1636205A1
(en)
|
2003-06-12 |
2006-03-22 |
Novo Nordisk A/S |
Pyridinyl carbamates as hormone-sensitive lipase inhibitors
|
WO2005019220A2
(en)
|
2003-08-11 |
2005-03-03 |
Cellular Genomics Inc. |
Substituted imidazo[1,2-a]pyrazines as modulators of kinase activity
|
US7411083B2
(en)
|
2003-09-25 |
2008-08-12 |
Wyeth |
Substituted acetic acid derivatives
|
EP2314576A1
(en)
|
2003-11-05 |
2011-04-27 |
F.Hoffmann-La Roche Ag |
Phenyl derivatives as PPAR agonists
|
EP1687268A1
(en)
|
2003-11-10 |
2006-08-09 |
Schering Aktiengesellschaft |
Benzylether amine compounds useful as ccr-5 antagonists
|
WO2005055929A2
(en)
|
2003-12-02 |
2005-06-23 |
Celgene Corporation |
Methods and compositions for the treatment and management of hemoglobinopathy and anemia
|
US7378439B2
(en)
|
2004-01-20 |
2008-05-27 |
Usv, Ltd. |
Process for the preparation of 4-(2-dipropylaminoethyl)-1,3-dihydro-2H-indol-2-one hydrochloride
|
WO2005074513A2
(en)
|
2004-01-30 |
2005-08-18 |
Merck & Co., Inc. |
N-benzyl-3,4-dihyroxypyridine-2-carboxamide and n-benzyl-2,3-dihydroxypyridine-4-carboxamide compounds useful as hiv integrase inhibitors
|
GB0403038D0
(en)
|
2004-02-11 |
2004-03-17 |
Novartis Ag |
Organic compounds
|
CA2557926A1
(en)
|
2004-03-09 |
2005-09-22 |
Monica Donghi |
Hiv integrase inhibitors
|
WO2005086951A2
(en)
|
2004-03-10 |
2005-09-22 |
Threshold Pharmaceuticals, Inc. |
Hypoxia-activated anti-cancer agents
|
DE102004015226B3
(de)
|
2004-03-24 |
2005-08-25 |
Siemens Ag |
Verfahren zum Plasmareinigen eines Werkstücks und zu dessen Durchführung geeignete Vorrichtung
|
CA2563752A1
(en)
|
2004-04-22 |
2005-11-03 |
Allos Therapeutics, Inc. |
Compositions of allosteric hemoglobin modifiers and methods of making the same
|
TW200606133A
(en)
|
2004-06-30 |
2006-02-16 |
Sankyo Co |
Substituted benzene compounds
|
TW200606129A
(en)
|
2004-07-26 |
2006-02-16 |
Chugai Pharmaceutical Co Ltd |
Novel cyclohexane derivative, its prodrug, its salt and diabetic therapeutic agent containing the same
|
GB0420722D0
(en)
|
2004-09-17 |
2004-10-20 |
Addex Pharmaceuticals Sa |
Novel allosteric modulators
|
CA2585165A1
(en)
|
2004-10-28 |
2006-05-18 |
Medicure International Inc. |
Dual antiplatelet/anticoagulant pyridoxine analogs
|
US20080287399A1
(en)
|
2004-12-14 |
2008-11-20 |
Astrazeneca Ab |
Substituted Aminopyridines and Uses Thereof
|
US7968574B2
(en)
|
2004-12-28 |
2011-06-28 |
Kinex Pharmaceuticals, Llc |
Biaryl compositions and methods for modulating a kinase cascade
|
WO2006088173A1
(ja)
|
2005-02-21 |
2006-08-24 |
Shionogi & Co., Ltd. |
Hivインテグラーゼ阻害活性を有する2環性カルバモイルピリドン誘導体
|
BRPI0608714A2
(pt)
|
2005-03-19 |
2010-01-26 |
Amorepacific Corp |
compostos, isÈmeros dos mesmos, ou sais farmaceuticamente aceitáveis dos mesmos como antagonista do receptor vanilóide, e composições farmacêuticas contendo os mesmos
|
WO2006106711A1
(ja)
|
2005-03-30 |
2006-10-12 |
Eisai R & D Management Co., Ltd. |
ピリジン誘導体を含有する抗真菌剤
|
GB0506677D0
(en)
|
2005-04-01 |
2005-05-11 |
Btg Int Ltd |
Iron modulators
|
EP1874117B8
(en)
|
2005-04-28 |
2014-03-12 |
VIIV Healthcare Company |
Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activity
|
DE102005025989A1
(de)
|
2005-06-07 |
2007-01-11 |
Bayer Cropscience Ag |
Carboxamide
|
JP2006342115A
(ja)
|
2005-06-10 |
2006-12-21 |
Shionogi & Co Ltd |
Hivインテグラーゼ阻害活性を有する多環性化合物
|
WO2007003962A2
(en)
|
2005-06-30 |
2007-01-11 |
Prosidion Limited |
Gpcr agonists
|
CN100562514C
(zh)
|
2005-07-22 |
2009-11-25 |
中国科学院上海药物研究所 |
一类取代丙酰胺衍生物、其制备方法和用途
|
GB0516270D0
(en)
|
2005-08-08 |
2005-09-14 |
Glaxo Group Ltd |
Novel compounds
|
CN101360731B
(zh)
|
2005-10-11 |
2013-01-30 |
联邦高等教育系统-匹兹堡大学 |
作为淀粉样发生蛋白成像剂的同位素标记苯并呋喃化合物
|
JP5131689B2
(ja)
|
2005-10-27 |
2013-01-30 |
塩野義製薬株式会社 |
Hivインテグラーゼ阻害活性を有する多環性カルバモイルピリドン誘導体
|
EP1948614A2
(en)
|
2005-11-18 |
2008-07-30 |
Takeda San Diego, Inc. |
Glucokinase activators
|
WO2007084914A2
(en)
|
2006-01-17 |
2007-07-26 |
Neurocrine Biosciences, Inc. |
Phenoxy-substituted pyrimidines as adenosine receptor antagonists
|
WO2007095495A2
(en)
|
2006-02-13 |
2007-08-23 |
Pharmacopeia, Inc. |
Benzodiazepine gcnf modulators for stem cell modulation
|
RU2318818C1
(ru)
|
2006-04-12 |
2008-03-10 |
Общество С Ограниченной Ответственностью "Исследовательский Институт Химического Разнообразия" |
Азагетероциклы, комбинаторная библиотека, фокусированная библиотека, фармацевтическая композиция и способ получения (варианты)
|
GB0614586D0
(en)
|
2006-07-22 |
2006-08-30 |
Pliva Istrazivacki Inst D O O |
Pharmaceutical Formulation
|
CN101113148A
(zh)
|
2006-07-26 |
2008-01-30 |
中国海洋大学 |
二氧哌嗪类化合物及其制备方法和用途
|
KR101410318B1
(ko)
|
2006-07-27 |
2014-06-27 |
(주)아모레퍼시픽 |
바닐로이드 수용체 길항제로서의 신규 화합물, 그의 이성질체, 또는 약제학적으로 허용가능한 그의 염, 및 이를함유하는 약제학적 조성물
|
TW200817424A
(en)
|
2006-08-04 |
2008-04-16 |
Daiichi Sankyo Co Ltd |
Benzylphenyl glucopyranoside derivatives
|
TWI389895B
(zh)
|
2006-08-21 |
2013-03-21 |
Infinity Discovery Inc |
抑制bcl蛋白質與結合夥伴間之交互作用的化合物及方法
|
JP5466006B2
(ja)
|
2006-09-03 |
2014-04-09 |
テックフィールズ バイオケム カンパニー リミテッド |
非常に速い皮膚浸透率を有するアセトアミノフェン及び関連化合物の正荷電水溶性プロドラッグ
|
KR101129868B1
(ko)
|
2006-10-04 |
2012-04-12 |
화이자 프로덕츠 인코포레이티드 |
칼슘 수용체 길항제로서의 피리도[4,3-d]피리미딘-4(3H)-온 유도체
|
WO2008051532A1
(en)
|
2006-10-23 |
2008-05-02 |
Merck & Co., Inc. |
2-[1-phenyl-5-hydroxy or methoxy-4alpha-methyl-hexahydroclopenta[f]indazol-5-yl]ethyl phenyl derivatives as glucocorticoid receptor ligands
|
CA2670984A1
(en)
|
2006-11-30 |
2008-06-05 |
Tokyo Institute Of Technology |
Novel curcumin derivative
|
FR2909379B1
(fr)
|
2006-11-30 |
2009-01-16 |
Servier Lab |
Nouveaux derives heterocycliques,leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
|
TW200835687A
(en)
|
2006-11-30 |
2008-09-01 |
R Tech Ueno Ltd |
Thiazole derivatives and their use as VAP-1 inhibitor
|
RU2487119C2
(ru)
|
2007-02-22 |
2013-07-10 |
Зингента Партисипейшнс Аг |
Производные иминопиридина и их применение в качестве микробиоцидов
|
TWI407960B
(zh)
|
2007-03-23 |
2013-09-11 |
Jerini Ag |
小分子緩激肽b2受體調節劑
|
CN101679172B
(zh)
|
2007-05-22 |
2013-05-29 |
住友化学株式会社 |
苯甲醛化合物的制造方法
|
WO2009001214A2
(en)
|
2007-06-28 |
2008-12-31 |
Pfizer Products Inc. |
Thieno[2,3-d]pyrimidin-4(3h)-one, isoxazolo[5,4-d]pyrimidin-4(5h)-one and isothiazolo[5,4-d]pyrimidin-4(5h)-one derivatives as calcium receptor antagonists
|
US20090069288A1
(en)
|
2007-07-16 |
2009-03-12 |
Breinlinger Eric C |
Novel therapeutic compounds
|
RU2440989C2
(ru)
|
2007-07-17 |
2012-01-27 |
Ф.Хоффманн-Ля Рош Аг |
ИНГИБИТОРЫ 11β-ГИДРОКСИСТЕРОИДНОЙ ДЕГИДРОГЕНАЗЫ
|
WO2009013335A1
(en)
|
2007-07-26 |
2009-01-29 |
Novartis Ag |
Organic compounds
|
TW200918521A
(en)
|
2007-08-31 |
2009-05-01 |
Astrazeneca Ab |
Heterocyclic amides and methods of use thereof
|
CN101827844B
(zh)
|
2007-10-17 |
2013-08-14 |
诺瓦提斯公司 |
可用作ALK抑制剂的咪唑并[1,2-a]吡啶衍生物
|
RS53877B1
(en)
|
2007-12-04 |
2015-08-31 |
F. Hoffmann-La Roche Ag. |
IZOKSAZOL-PYRIDINE DERIVATIVES
|
US7776875B2
(en)
|
2007-12-19 |
2010-08-17 |
Hoffman-La Roche Inc. |
Spiroindolinone derivatives
|
JP2009203230A
(ja)
|
2008-01-31 |
2009-09-10 |
Daiichi Sankyo Co Ltd |
ベンジルフェニルグルコピラノシド誘導体を含有する医薬組成物
|
DK2241546T3
(da)
|
2008-02-14 |
2017-11-13 |
Sumitomo Chemical Co |
Fremgangsmåde til fremstilling af en benzaldehydforbindelse
|
US8268834B2
(en)
*
|
2008-03-19 |
2012-09-18 |
Novartis Ag |
Pyrazine derivatives that inhibit phosphatidylinositol 3-kinase enzyme
|
US8633245B2
(en)
|
2008-04-11 |
2014-01-21 |
Institute Of Medicinal Molecular Design, Inc. |
PAI-1 inhibitor
|
AU2009234899A1
(en)
|
2008-04-11 |
2009-10-15 |
Institute Of Medicinal Molecular Design, Inc. |
PAI-1 inhibitor
|
JP2011136906A
(ja)
|
2008-04-18 |
2011-07-14 |
Otsuka Pharmaceut Co Ltd |
複素環化合物
|
US8119647B2
(en)
|
2008-04-23 |
2012-02-21 |
Glenmark Pharmaceuticals S.A. |
Fused pyrimidineone compounds as TRPV3 modulators
|
CA2723233C
(en)
|
2008-05-08 |
2017-06-13 |
Nova Southeastern University |
Specific inhibitors for vascular endothelial growth factor receptors
|
RU2010153656A
(ru)
|
2008-06-04 |
2012-07-20 |
Амбрилиа Байофарма Инк. (Ca) |
Ингибиторы интегразы вич из пиридоксина
|
DE102008027574A1
(de)
|
2008-06-10 |
2009-12-17 |
Merck Patent Gmbh |
Neue Pyrrolidinderivate als MetAP-2 Inhibitoren
|
JP5314330B2
(ja)
|
2008-06-16 |
2013-10-16 |
住友化学株式会社 |
2−(アリールオキシメチル)ベンズアルデヒドの製造方法およびその中間体
|
GB0811451D0
(en)
|
2008-06-20 |
2008-07-30 |
Syngenta Participations Ag |
Novel microbiocides
|
AR073304A1
(es)
|
2008-09-22 |
2010-10-28 |
Jerini Ag |
Moduladores del receptor de bradiquinina b2 de molecula pequena
|
US8815875B2
(en)
|
2008-11-12 |
2014-08-26 |
Merck Sharp & Dohme Corp. |
Inhibitors of fatty acid binding protein (FABP)
|
TW201033201A
(en)
|
2009-02-19 |
2010-09-16 |
Hoffmann La Roche |
Isoxazole-isoxazole and isoxazole-isothiazole derivatives
|
ES2811342T3
(es)
|
2009-03-31 |
2021-03-11 |
Ligand Pharm Inc |
Antagonista de receptores de endotelina y angiotensina II de bifenilsulfonamida para tratar glomeruloesclerosis y nefropatía inducida por IgA
|
ES2440000T3
(es)
|
2009-05-08 |
2014-01-27 |
Tetraphase Pharmaceuticals, Inc. |
Compuestos de 8-aza-tetraciclina
|
WO2011024869A1
(ja)
|
2009-08-26 |
2011-03-03 |
武田薬品工業株式会社 |
縮合複素環誘導体およびその用途
|
US20120245344A1
(en)
|
2009-08-31 |
2012-09-27 |
Nippon Chemiphar Co., Ltd. |
Gpr119 agonist
|
MX2012003170A
(es)
|
2009-09-21 |
2012-04-11 |
Hoffmann La Roche |
Compuestos heterociclicos antivirales.
|
EP2498756B2
(en)
|
2009-11-09 |
2023-02-15 |
Wyeth LLC |
Tablet formulations of neratinib maleate
|
TW201139406A
(en)
|
2010-01-14 |
2011-11-16 |
Glaxo Group Ltd |
Voltage-gated sodium channel blockers
|
KR101698153B1
(ko)
|
2010-04-26 |
2017-01-23 |
광주과학기술원 |
P2x1 및 p2x3 수용체 길항제로 사용되는 신규한 피리딘 카르복실산계 화합물, 이의 제조방법 및 이를 포함하는 조성물
|
CN102232949A
(zh)
|
2010-04-27 |
2011-11-09 |
孙远 |
提高药物溶出度的组合物及其制备方法
|
TWI535442B
(zh)
|
2010-05-10 |
2016-06-01 |
Kyowa Hakko Kirin Co Ltd |
A nitrogen-containing heterocyclic compound having an action of inhibiting the production of canine erythritine
|
US8633317B2
(en)
*
|
2010-06-09 |
2014-01-21 |
Abbvie Inc. |
Crystalline salts of thieno[3,2-c]pyridine kinase inhibitors with improved cpy safety profile
|
US20120122928A1
(en)
|
2010-08-11 |
2012-05-17 |
Bayer Cropscience Ag |
Heteroarylpiperidine and -Piperazine Derivatives as Fungicides
|
CN102116772B
(zh)
|
2010-09-28 |
2013-08-28 |
上海大学 |
二氢查尔酮化合物的筛选方法
|
JP2014501224A
(ja)
|
2010-12-27 |
2014-01-20 |
武田薬品工業株式会社 |
口腔内崩壊錠
|
WO2012138981A2
(en)
|
2011-04-06 |
2012-10-11 |
Teva Pharmaceutical Industries Ltd. |
New intermediates and processes for preparing ticagrelor
|
RU2625790C2
(ru)
|
2011-04-11 |
2017-07-19 |
Грин Тек Ко.,Лтд. |
Новое пиразольное производное
|
CN102952062B
(zh)
|
2011-08-12 |
2016-06-08 |
中国医学科学院医药生物技术研究所 |
取代苯并杂环类化合物及其制备方法和应用
|
CN103857397B
(zh)
*
|
2011-09-15 |
2016-08-17 |
德莫科斯公司 |
降伊波加因碱盐非溶剂化物
|
WO2013052803A2
(en)
|
2011-10-07 |
2013-04-11 |
Radiorx, Inc. |
Methods and compositions comprising a nitrite-reductase promoter for treatment of medical disorders and preservation of blood products
|
PT3738434T
(pt)
|
2011-12-28 |
2023-11-13 |
Global Blood Therapeutics Inc |
Intermediários para obter compostos de benzaldeído substituído e métodos para a sua utilização no aumento da oxigenação de tecidos
|
ES2790358T3
(es)
|
2011-12-28 |
2020-10-27 |
Global Blood Therapeutics Inc |
Compuestos de heteroaril aldehído sustituido y métodos para su uso en el aumento de la oxigenación tisular
|
BR112015015216B1
(pt)
|
2012-12-27 |
2020-01-07 |
Sumitomo Chemical Company, Limited |
Composto de tetrazolinona, agente e método de controle de peste
|
WO2014145040A1
(en)
|
2013-03-15 |
2014-09-18 |
Global Blood Therapeutics, Inc. |
Substituted aldehyde compounds and methods for their use in increasing tissue oxygenation
|
US10266551B2
(en)
|
2013-03-15 |
2019-04-23 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
EP2968295A1
(en)
|
2013-03-15 |
2016-01-20 |
Global Blood Therapeutics, Inc. |
Compositions and methods for the modulation of hemoglobin (s)
|
US9422279B2
(en)
|
2013-03-15 |
2016-08-23 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
JP6401772B2
(ja)
|
2013-03-15 |
2018-10-10 |
グローバル ブラッド セラピューティクス インコーポレイテッド |
ヘモグロビンの修飾のための化合物及びその使用
|
EP2970184B1
(en)
|
2013-03-15 |
2018-12-05 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
US20150057251A1
(en)
|
2013-08-26 |
2015-02-26 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
US9604999B2
(en)
|
2013-03-15 |
2017-03-28 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
PE20160078A1
(es)
|
2013-03-15 |
2016-03-02 |
Global Blood Therapeutics Inc |
Compuestos y sus usos para modular la hemoglobina
|
US9458139B2
(en)
|
2013-03-15 |
2016-10-04 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
US20140271591A1
(en)
|
2013-03-15 |
2014-09-18 |
Global Blood Therapeutics, Inc. |
Compositions and methods for the modulation of hemoglobin (s)
|
US20140274961A1
(en)
|
2013-03-15 |
2014-09-18 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
US8952171B2
(en)
|
2013-03-15 |
2015-02-10 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
WO2014150276A1
(en)
|
2013-03-15 |
2014-09-25 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
US9802900B2
(en)
|
2013-03-15 |
2017-10-31 |
Global Blood Therapeutics, Inc. |
Bicyclic heteroaryl compounds and uses thereof for the modulation of hemoglobin
|
AP2015008721A0
(en)
|
2013-03-15 |
2015-09-30 |
Global Blood Therapeutics Inc |
Compounds and uses thereof for the modulation of hemoglobin
|
US20160206604A1
(en)
|
2013-08-26 |
2016-07-21 |
Global Blood Therapeutics, Inc. |
Formulations comprising wetting agents and compounds for the modulation of hemoglobin (s)
|
US20160207904A1
(en)
|
2013-08-27 |
2016-07-21 |
Global Blood Therapeutics, Inc. |
Crystalline 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde ansolvate salts
|
WO2015031285A1
(en)
|
2013-08-27 |
2015-03-05 |
Global Blood Therapeutics, Inc. |
Crystalline 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde ansolvate salts
|
EA201992707A1
(ru)
|
2013-11-18 |
2020-06-30 |
Глобал Блад Терапьютикс, Инк. |
Соединения и их применения для модуляции гемоглобина
|
US20150141465A1
(en)
|
2013-11-18 |
2015-05-21 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
WO2015116061A1
(en)
|
2014-01-29 |
2015-08-06 |
Global Blood Therapeutics, Inc. |
1:1 adducts of sickle hemoglobin
|
US9248199B2
(en)
|
2014-01-29 |
2016-02-02 |
Global Blood Therapeutics, Inc. |
1:1 adducts of sickle hemoglobin
|
AP2016009261A0
(en)
|
2014-02-07 |
2016-06-30 |
Global Blood Therapeutics Inc |
Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde
|
WO2016043849A2
(en)
|
2014-07-24 |
2016-03-24 |
Global Blood Therapeutics, Inc. |
Compounds for treating acute respiratory distress syndrome or a negative effect thereof
|
TWI544395B
(zh)
|
2014-09-26 |
2016-08-01 |
義隆電子股份有限公司 |
單層電容式觸控面板之掃描方法及裝置
|
MA41841A
(fr)
|
2015-03-30 |
2018-02-06 |
Global Blood Therapeutics Inc |
Composés aldéhyde pour le traitement de la fibrose pulmonaire, de l'hypoxie, et de maladies auto-immunes et des tissus conjonctifs
|
SG10201912511WA
(en)
|
2015-12-04 |
2020-02-27 |
Global Blood Therapeutics Inc |
Dosing regimens for 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde
|
TWI663160B
(zh)
|
2016-05-12 |
2019-06-21 |
全球血液治療公司 |
用於合成2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)-吡啶-3-基)甲氧基)苯甲醛之方法
|
TWI778983B
(zh)
|
2016-10-12 |
2022-10-01 |
美商全球血液治療公司 |
包含2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)吡啶-3-基)甲氧基)-苯甲醛之片劑
|
US11014884B2
(en)
|
2018-10-01 |
2021-05-25 |
Global Blood Therapeutics, Inc. |
Modulators of hemoglobin
|
MX2021005887A
(es)
|
2018-11-19 |
2021-09-14 |
Global Blood Therapeutics Inc |
Compuestos de 2-formil-3-hidroxifeniloximetilo capaces de modular hemoglobina.
|